Metabolic disorders and hepatitis: Insights from a Mendelian randomization study

doi:10.4240/wjgs.v16.i6.1775

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (83)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

HTML

Figures (1-5)

Tables (1-2)

Sum=82

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Jun 27, 2024 (publication date) through Jun 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastrointest Surg. Jun 27, 2024; 16(6): 1775-1790
Published online Jun 27, 2024. doi: 10.4240/wjgs.v16.i6.1775

Open in New Tab Full Size Figure Download Figure

Figure 1 Mendelian randomization analysis. MR: Mendelian randomization; SNP: Single nucleotide polymorphism.

Open in New Tab Full Size Figure Download Figure

Figure 2 Forest plot of the comorbidities. A and B: type 2 diabetes mellitus; C and D: Hyperlipidemia; E and F: Hypertension affecting chronic hepatitis B infection (upper panel) and chronic hepatitis C infection (lower panel). MR: Mendelian randomization.

Open in New Tab Full Size Figure Download Figure

Figure 3 Funnel plot of the comorbidities. A and B: Type 2 diabetes mellitus; C and D: Hyperlipidemia; E and F: Hypertension affecting chronic hepatitis B infection (upper panel) and chronic hepatitis C infection (lower panel). MR: Mendelian randomization.

Open in New Tab Full Size Figure Download Figure

Figure 4 Leave one-out plot of the comorbidities. A and B: Type 2 diabetes mellitus; C and D: Hyperlipidemia; E and F: Hypertension affecting chronic hepatitis B infection (upper panel) and chronic hepatitis C infection (lower panel). MR: Mendelian randomization.

Open in New Tab Full Size Figure Download Figure

Figure 5 Scatter plot of the comorbidities. A and B: Type 2 diabetes mellitus; C and D: Hyperlipidemia; E and F: Hypertension affecting chronic hepatitis B infection (upper panel) and chronic hepatitis C infection (lower panel). MR: Mendelian randomization.

Citation: Liang LB, Liu XP, Mao TR, Su QL. Metabolic disorders and hepatitis: Insights from a Mendelian randomization study. World J Gastrointest Surg 2024; 16(6): 1775-1790
URL: https://www.wjgnet.com/1948-9366/full/v16/i6/1775.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i6.1775